Analysis on the Clinical Dosage of Guizhi（Ramulus Cinnamoni） in Different Ages

FU Yanling; ZHANG Lin; CHEN Liming

doi:10.13288/j.11-2166/r.2014.14.017

您当前的位置：

首页 >

文章列表页 >

Analysis on the Clinical Dosage of Guizhi（Ramulus Cinnamoni） in Different Ages

更新时间：2021-11-17

- Analysis on the Clinical Dosage of Guizhi（Ramulus Cinnamoni） in Different Ages
- Journal of Traditional Chinese Medicine Vol. 55, Issue 14, Pages: 1230-1233(2014)
- 作者机构：
  
  北京中医药大学继续教育学院、基础医学院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2014.14.017
  CLC： R289
- Published：2014
- 稿件说明：
移动端阅览
[1]傅延龄,张林,陈丽名.桂枝历代临床用量分析[J].中医杂志,2014,55(14):1230-1233.

FU Yanling, ZHANG Lin, CHEN Liming. Analysis on the Clinical Dosage of Guizhi（Ramulus Cinnamoni） in Different Ages[J]. Journal of Traditional Chinese Medicine2014, 55(14): 1230-1233.
[1]傅延龄,张林,陈丽名.桂枝历代临床用量分析[J].中医杂志,2014,55(14):1230-1233. DOI： 10.13288/j.11-2166/r.2014.14.017.

FU Yanling, ZHANG Lin, CHEN Liming. Analysis on the Clinical Dosage of Guizhi（Ramulus Cinnamoni） in Different Ages[J]. Journal of Traditional Chinese Medicine2014, 55(14): 1230-1233. DOI： 10.13288/j.11-2166/r.2014.14.017.

摘要

目的总结桂枝从汉代至今两千多年的临床用量特点

为桂枝临床用量策略制定提供依据。方法建立从汉代至今桂枝剂量数据库

选取各朝代最具代表的医学著作

将含桂枝方剂的方名、总药量、桂枝药量、整方药味数、加水量、服法等逐一录入。统计含桂枝方剂中桂枝出现的频次、最常用量、常用量上限、常用量下限、最大用量、最小用量、平均用量。结果整个汉唐宋时期

桂枝的用量范围很大

平均用量均在20g以上;金元以后桂枝用量逐渐减少;至明清以后

由于温病学说盛行

桂枝作为一味辛温药物

其平均用量和最常用量都处于一个低剂量范围

但仍有一些医家在治疗某些病例时应用大剂量的桂枝

最大用量达298.4g。结论桂枝超大剂量使用

发汗解肌力量较强

可治疗风寒表虚感冒久不能解者;大剂量主要用于温经通脉。

Abstract

Objective To summarize the clinical dosage of Guizhi（Ramulus Cinnamomi

桂枝） since the Han Dynasties（2000 years ago） and provide a basis for formulating the clinical dosage strategy of Guizhi. Methods The database of clinical dosage of Guizhi through ages was established. The formulas containing Guizhi in the most representative medical books were selected and the formula name

total dosage

dosage of Guizhi

herb numbers in a formula

water consumption in decoction and method of administration were recorded. The frequency

the most common dosage

the upper limit of usual dose

the lower limit of usual dose

the maximum dosage

the minimum dosage and the average dosage of Guizhi were analyzed. The dosage characteristics of Guizhi through ages were analyzed.Results The dosage of Guizhi was large in the Han-Tang-Song Dynasties

with an average dosage of more than 20 g.The dosage of Guizhi was gradually reduced since the Jin-Yuan Dynasties. As a warm acrid herb

the average dosage and common dosage of Guizhi was decreased after the Ming and Qing Dynasties because of the prevalence of epidemic febrile disease theory. But some doctors still used large dose of Guizhi to treat some diseases with a maximum dosage of 298. 4 g. Conclusion The extra large dose of Guizhi is used to treat common cold with wind-cold exterior deficiency syndrome. The large dose of Guizhi is used to warm the channels and free the vessels.

关键词

Keywords

references

查看原文

Views

584

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Literature Analysis of the Clinical Dosage of Dahuang （Radix et Rhizoma Rhei） from Eastern Han Dynasty to the Present

High and Low Dose Principle in the Combination of Medicinals

Discussion on Symmetry of Prescription

Dose of Gegen Qinlian Decoction for Diarrhea in Clinic

Discussion on Three Kinds of Formula Mode in the History of Prescription

Related Author

WANG Xueqian

CHENG Fafeng

LI Ting

CHEN Jiahui

CHEN Dan

REN Zilin

Shoukang LU

DU Guangli

Related Institution

Dongzhimen Hospital，Beijing University of Chinese Medicine

School of Traditional Chinese Medicine，Beijing University of Chinese Medicine

Beijing University of Chinese Medicine

School of Chinese Materia Medica,Shanghai University of Chinese Medicine

Guang’ anmen Hospital,China Academy of Chinese Medical Sciences

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰